Theranostic role of 89 Zr- and 177 Lu-labeled aflibercept in breast cancer.
Qi YangZhao ChenYongkang QiuWenpeng HuangTianyao WangLele SongXinyao SunCuicui LiXiaojie XuLei KangPublished in: European journal of nuclear medicine and molecular imaging (2023)
Lu-labeled Abe could be a TNBC-specific marker with diagnostic value and provide insights into targeted therapy in the treatment of TNBC. Further clinical evaluation and translation may be of high significance for TNBC.